» Articles » PMID: 15962011

Sprouty2 Acts at the Cbl/CIN85 Interface to Inhibit Epidermal Growth Factor Receptor Downregulation

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2005 Jun 18
PMID 15962011
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitin ligase Cbl mediates ubiquitination of activated receptor tyrosine kinases (RTKs) and interacts with endocytic scaffold complexes, including CIN85/endophilins, to facilitate RTK endocytosis and degradation. Several mechanisms regulate the functions of Cbl to ensure the fine-tuning of RTK signalling and cellular homeostasis. One regulatory mechanism involves the binding of Cbl to Sprouty2, which sequesters Cbl away from activated epidermal growth factor receptors (EGFRs). Here, we show that Sprouty2 associates with CIN85 and acts at the interface between Cbl and CIN85 to inhibit EGFR downregulation. The CIN85 SH3 domains A and C bind specifically to proline-arginine motifs present in Sprouty2. Intact association between Sprouty2, Cbl and CIN85 is required for inhibition of EGFR endocytosis as well as EGF-induced differentiation of PC12 cells. Moreover, Sprouty4, which lacks CIN85-binding sites, does not inhibit EGFR downregulation, providing a molecular explanation for functional differences between Sprouty isoforms. Sprouty2 therefore acts as an inducible inhibitor of EGFR downregulation by targeting both the Cbl and CIN85 pathways.

Citing Articles

SPROUTY2, a Negative Feedback Regulator of Receptor Tyrosine Kinase Signaling, Associated with Neurodevelopmental Disorders: Current Knowledge and Future Perspectives.

Puranik N, Jung H, Song M Int J Mol Sci. 2024; 25(20).

PMID: 39456824 PMC: 11507918. DOI: 10.3390/ijms252011043.


Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice.

Altes G, Olomi A, Perramon-Guell A, Hernandez S, Casanovas A, Perez A Sci Rep. 2024; 14(1):19479.

PMID: 39174793 PMC: 11341818. DOI: 10.1038/s41598-024-70529-w.


Sprouty1 is a broad mediator of cellular senescence.

Anerillas C, Perramon-Guell A, Altes G, Cuesta S, Vaquero M, Olomi A Cell Death Dis. 2024; 15(4):296.

PMID: 38670941 PMC: 11053034. DOI: 10.1038/s41419-024-06689-4.


Studying the Association of TKS4 and CD2AP Scaffold Proteins and Their Implications in the Partial Epithelial-Mesenchymal Transition (EMT) Process.

Kurilla A, Laszlo L, Takacs T, Tilajka A, Lukacs L, Novak J Int J Mol Sci. 2023; 24(20).

PMID: 37894817 PMC: 10606890. DOI: 10.3390/ijms242015136.


PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability.

Martinez N, Gragera T, de Lucas M, Camara A, Ballester A, Anta B Oncogenesis. 2023; 12(1):20.

PMID: 37045830 PMC: 10097667. DOI: 10.1038/s41389-023-00465-3.


References
1.
Wong E, Lim J, Low B, Chen Q, Guy G . Evidence for direct interaction between Sprouty and Cbl. J Biol Chem. 2000; 276(8):5866-75. DOI: 10.1074/jbc.M006945200. View

2.
Kowanetz K, Crosetto N, Haglund K, Schmidt M, Heldin C, Dikic I . Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem. 2004; 279(31):32786-95. DOI: 10.1074/jbc.M403759200. View

3.
Petrelli A, Gilestro G, Lanzardo S, Comoglio P, Migone N, Giordano S . The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature. 2002; 416(6877):187-90. DOI: 10.1038/416187a. View

4.
Egan J, Hall A, Yatsula B, Bar-Sagi D . The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc Natl Acad Sci U S A. 2002; 99(9):6041-6. PMC: 122898. DOI: 10.1073/pnas.052090899. View

5.
Wong E, Fong C, Lim J, Yusoff P, Low B, Langdon W . Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J. 2002; 21(18):4796-808. PMC: 126289. DOI: 10.1093/emboj/cdf493. View